NHE1 inhibition with cariporide reversed imatinib resistance in BCR-ABL-expressing leukemia cells[98-100], and NHE1 knockdown sensitized malignant cells to cisplatin-induced apoptosis[101]. This evidence concerns the gene SLC9A1 and leukemia.